Citation

Jeffery RM, Dickinson L, Ng ND, DeGeorge LM, Nable JV. J. Am. Coll. Health 2017; 65(3): 212-216.

Affiliation

MedStar Georgetown University Hospital, Georgetown University School of Medicine , Washington , DC , USA.

Copyright

(Copyright © 2017, Informa - Taylor and Francis Group)

DOI

10.1080/07448481.2016.1277730

PMID

28059635

Abstract

Opioid abuse is a growing and significant public health concern in the United States. Naloxone is an opioid antagonist that can rapidly reverse the respiratory depression associated with opioid toxicity. Georgetown University's collegiate-based emergency medical services (EMS) agency recently adopted a protocol allowing providers to administer intranasal naloxone for patients with suspected opioid overdose. While normally not within the scope of practice of basic life support prehospital agencies, the recognition of an increasing epidemic of opioid abuse has led many states, including the District of Columbia, to expand access to naloxone for prehospital providers of all levels of training. In particular, intranasal naloxone is a method of administering this medication that potentially avoids needlestick injuries among EMS providers. Universities with collegiate-based EMS agencies are well-positioned to provide life-saving treatments for patients acutely-ill from opioid overdose.

Language: en